Clinical Trials Browser

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

NCT07046936 2026-03-03

MITO-RES

Recruiting

30 enrolled

Tumor-Agnostic

Neoplasms

NCT03830320 2026-02-27

Positron Emission Tomography (PET) Imaging of Thrombosis

Phase 1 Recruiting

165 enrolled

COVID-19, Atrial Fibrillation, Neoplasms, Thrombosis

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Recruiting

50 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT01915797 2026-02-13

TED

Completed

998 enrolled

Tumor-Agnostic

Neoplasms

NCT00349830 2026-02-10

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Recruiting

2,000 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasms

NCT07401355 2026-02-10

LIGHT-CTC

Phase NA Not yet recruiting

100 enrolled

Sarcoma

Neoplasms, Sarcoma

NCT06674811 2026-01-26

BRICCS

Recruiting

40 enrolled

CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NCT06826066 2026-01-15

TRANSPROUST

Phase NA Recruiting

40 enrolled

Tumor-Agnostic

Neoplasms

NCT01492036 2026-01-07

Long-Term Follow-Up of Recipient of Gene Transfer Research

Recruiting

130 enrolled

Neoplasms, Retroviridae Infections

NCT06479070 2025-12-24

CIRADOR

Phase NA Recruiting

188 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

Clinical Trials

PALANGI3

MITO-RES

Positron Emission Tomography (PET) Imaging of Thrombosis

PARIB-OLD-PRO²

TED

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

LIGHT-CTC

BRICCS

TRANSPROUST

Long-Term Follow-Up of Recipient of Gene Transfer Research

CIRADOR